КЛИНИЧЕСКИЙ СЛУЧАЙ

Применение лазерной коагуляции сетчатки при болезни Илза

Информация об авторах

Российский национальный исследовательский медицинский университет имени Н. И. Пирогова, Москва, Россия

Для корреспонденции: Екатерина Павловна Тебина
Волоколамское шоссе, д. 30, корп. 2, г. Москва, 123182; ur.liam@anibetaniretake

Информация о статье

Вклад авторов: Х. П. Тахчиди — концепция и дизайн исследования, редактирование текста; Е. Х. Тахчиди — анализ литературных данных; Е. П. Тебина — написание текста; Т. А. Касмынина — лазерное лечение пациента; М. В. Мокрунова — сбор и обработка материала.

Статья получена: 20.09.2020 Статья принята к печати: 12.10.2020 Опубликовано online: 23.10.2020
|
  1. Therese KL, Deepa P, Therese J, Bagyalakshmi R, Biswas J, Madhavan HN. Asso-ciation of mycobacteria with Eales’ disease. Indian J Med Res. 2007; 126: 56–62.
  2. Yannuzzi LA. The Retinal Atlas. Retinal Vascular Diseases, Eales’ Disease. Elsevier. 2010: 433–8.
  3. Das T, Pathengay A, Hussain N, Biswas J. Eales’ disease: diagnosis and management. Eye. 2010; 24 (3): 472–82.
  4. Eales H. Retinal haemorrhages associated with epistaxis and constipation. Brim Med. 1880; 9: 262.
  5. Madhavan HN, Therese KL, Doraiswamy K. Further investigations on the association of Mycobacterium tuberculosis with Eales' disease. Indian J Ophthalmol. 2002; 50: 35–39.
  6. Patwardhan SD, Azad E, Shah BM, Sharma Y. Role of intravitreal bevacizumab in Eales disease with dense vitreous haemorrhage: a prospective randomized control study. Retina. 2011; 31 (5): 866–70.
  7. Biswas J, K R R, Pal B, Gondhale HP, Kharel Sitaula R. Long- Term Outcomes of a Large Cohort of Patients with Eales' Disease. Ocul Immunol Inflamm. 2018; 26 (6): 870–6.
  8. Sen A, Paine SK, Chowdhury IH, Mukherjee A, Choudhury S, Mandal LK, Bhattacharya B. Assessment of gelatinase and tumor necrosis factor-alpha level in the vitreous and serum of patients with Eales disease; role of inflammation-mediated angio-genesis in the pathogenesis of Eales disease. Retina. 2011; 31 (7): 1412–20.
  9. Saxena S, Kumar D. Macular involvement in Eales disease. Ann Ophthalmol. 2000; 32 (2): 98–100.
  10. Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol. 2014; 28: 95–103.
  11. Kumar V, Chandra P, Kumar A. Ultra-wide field angiography in the management of Eales disease. Indian J Ophthalmol. 2016; 64: 504–7.
  12. Mwndoza KA, Lauer A. Eales Disease. American Academy of Ophthalmology. 2015. Available from: http://eyewiki.org/Eales_ Disease.
  13. Saxena S, Kumar D. New classification system-based visual outcome in Eales’disease. Indian J Ophthalmol. 2007; 55 (4): 267–9.
  14. Biswas J, Ravi RK, Naryanasamy A, Kulandai LT, Madhavan HN. Eales’ disease — current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013; 3: 11.
  15. Das TP, Namperumalsamy P. Photocoagulation in Eales’ disease. Results of pro-spective randomised clinical study. Presented in XXVI Int Cong Ophthalmol – Singapore, 1990.
  16. Ishaq M, Niazi MK. Usefulness of laser photocoagulation in managing asymptomatic eyes of Eales disease. J Ayub Med Coll Abbottabad. 2002; 14 (4): 22–25.
  17. Ishaq M, Feroze AH, Shahid M, Baig MA, Ameen SS, Feroze SH, Chishti RA. Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series. Eye (Lond). 2007; 21: 1403–5.
  18. Kumar A, Sinha S. Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab. Can J Ophthalmol. 2007; 42 (2): 335–6.
  19. Magargal LE, Walsh AW, Magargal HO, et al. Treatment of Eales’ disease with scat-ter laser photocoagulation. Ann Ophthalmol. 1989; 21: 300–2.
  20. Talat L, Lightman S, Tomkins-netzer O. Ischemic retinal vasculitis and its manage-ment. J Ophthalmol. 2014; 2014: 197675.
  21. Li J, Liu SM, Dong WT, Li F, Zhou CH, Xu XD, Zhong J. Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases. Int J Ophthalmol. 2018; 11 (3): 408–15.
  22. El-Asrar AM, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease). Br J Ophthalmol. 2002; 86 (11): 1248–51.
  23. Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Mashayekhi A, Naghibozakerin J. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease. Eur J Ophthalmol. 2005; 15 (3): 379–83.
  24. Gopal L, Abraham C. Efficacy of photocoagulation in Eales’ disease. Trans Asia-Pacific Acad. 1985; 10: 689.
  25. Nada M, Qanoongo S, Singh SV, Khurana AK. A rare presentation of exudative macroaneurysms in unilateral Eales' disease. Nepal J Ophthalmol. 2017; 9 (18): 95–98.
  26. Murphy RP, Gieser SC, Fine SL, et al. Retinal and vitreous findings in Eales disease. Invest Ophthalmol Vis Sci. 1986; 27: 121.
  27. Nicolcescu A, Mocanu C, Dinu L, Olaru A, Ionete M, Stefanescu DA. Unilateral Eales' disease a case report. Rom J Ophthalmol. 2017; 61 (2): 144–9.
  28. Педанова Е. К., Буряков Д. А. Эффективность лазеркоагуляции при болезни Илза в свете современных представлений об этиопатогенезе заболевания. Современные технологии лечения витреоретинальной патологии — 2013. 2013: 136. Доступно по ссылке: https://eyepress.ru/article.aspx?12646.
  29. Толстухина Е. А., Магарамов Д. А., Володин П. Л., Тимохов В. Л., aФомин А. В. Лазер-индуцированный регресс периферической ретинальной неоваскуляризации при болезни Илза (клинический случай). Современные технологии в офтальмологии. 2019; 1 (26): 381–3.
  30. Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol. 1999; 14 (4): 200–9.
  31. Moutray T, Evans JR, Lois N, Armstrong DJ, Peto T, Azuara- Blanco A. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2018; 3 (3): CD012314.
  32. Reddy SV, Husain D. Panretinal Photocoagulation: A Review of Complications. Semin Ophthalmol. 2018; 33 (1): 83–88.